Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Thu, 06/28/18 - 09:34 am
Tags:
Amgen, ABP 710, JNJ, Merck, Remicade, biosimilars, rheumatoid arthritis
Dare to 'Dreem': J&J Invests in Sleep-Focused Medtech Startup
Medical Devices and Diagnostics Industry
Tue, 06/26/18 - 10:07 pm
Tags:
Dreem, JNJ, devices, neurotech
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
Fierce Pharma
Mon, 06/25/18 - 09:12 pm
Tags:
JNJ, Invokana, diabetes, heart failure
J&J's Drug Unit Chief Expands Portfolio in Executive Shakeup
Yahoo/Bloomberg
Sat, 06/23/18 - 12:58 pm
Tags:
JNJ, Joaquin Duato, reorganization
Johnson & Johnson hits the Big Apple with latest JLabs site
Mass Device
Thu, 06/21/18 - 11:09 pm
Tags:
JNJ, New York, NYC, incubators, innovation
New York Judge's Ruling Could Be Painful For Opioid-Makers Sued Over Addiction Crisis
Forbes
Tue, 06/19/18 - 09:53 am
Tags:
New York, opioids, opioid crisis, Purdue Pharma, JNJ
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Mon, 06/18/18 - 09:47 am
Tags:
Indorsia, Actelion, JNJ, insomnia
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Fri, 06/15/18 - 09:57 am
Tags:
Novartis, biosimilars, JNJ, Remicade, Amgen, Enbrel, autoimmune disease
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
CP Wire
Wed, 06/13/18 - 10:19 pm
Tags:
JNJ, NICE, Tremfya, psoriasis
Wed, 06/13/18 - 10:25 am
Tags:
JNJ, Tremfya, psoriasis
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Drug Delivery Business News
Tue, 06/12/18 - 11:28 pm
Tags:
JNJ, M&A, LifeScan, blood glucose monitoring, devices
Is There an End in Sight for J&J Divestitures?
Medical Devices and Diagnostics Industry
Sun, 06/10/18 - 07:00 pm
Tags:
JNJ, M&A, LifeScan, Fortive, devices
J&J gets $2.7 billion offer for sterilization unit from Fortive
Yahoo/Reuters
Wed, 06/6/18 - 09:59 pm
Tags:
JNJ, Fortive, M&A, sterilzation, Ethicon
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
Endpoints
Thu, 05/31/18 - 08:11 pm
Tags:
JNJ, esketamine, major depression
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
Tue, 05/29/18 - 09:22 pm
Tags:
M&A, JNJ, Merck, Pfizer, Gilead Sciences, Amgen, Biogen, Takeda, Regeneron, Alexion
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
Tue, 05/29/18 - 11:36 am
Tags:
clinical trials, Roche, Genentech, Genmab, JNJ, cancer, Tecentriq, Darzalex
Danish biotech Genmab hit by ending of trial using key cancer drug
Reuters
Mon, 05/28/18 - 01:35 pm
Tags:
Genmab, JNJ, Janssen, Darzalex
Biopharma M&A: You Ain’t Seen Nothing Yet
Barron's
Fri, 05/25/18 - 09:32 am
Tags:
JNJ, Merck, Pfizer, Gilead Sciences, Amgen, Regeneron, Alexion, M&A
Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000
Fierce Pharma
Thu, 05/24/18 - 09:40 pm
Tags:
JNJ, lawsuit, mesothelioma
Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug
Medical Marketing and Media
Thu, 05/24/18 - 05:39 pm
Tags:
Sun Pharma, JNJ, Yonsa, prostate cancer, Zytiga

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.